Schedule 13G ownership disclosure
Annexon Inc
Common Stock, par value $0.001 per share · CUSIP: 03589W102
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BCLS I Investco, LP
Shares: 5,249,069 · Class: 4.9%
- BCIP Life Sciences Associates, LP
Shares: 0 · Class: 0%
- Bain Capital Life Sciences Fund, L.P.
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020417
- Form type
- SCHEDULE 13G/A
- Filer
- Annexon, Inc.
- CIK
- CIK 1528115
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership